New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 14, 2014
16:24 EDTC, TWTR, EW, MDT, GDP, AKBA, NQ, RTRXOn The Fly: Closing Wrap
Stocks on Wall Street were higher after U.S. retail sales for March surprised to the upside. The averages spent much of the session higher before losing altitude during the afternoon, with the Nasdaq even turning negative near 3:00 pm ET. An aggressive rally took hold in the final 30 minutes of trade, with the indexes closing just off their best levels of the day. ECONOMIC EVENTS: In the U.S., retail sales climbed 1.1% in March, beating expectations for an increase of 0.8%. Retail sales excluding autos rose 0.7%, which also beat estimates. Business inventories grew 0.4% in February, versus the consensus forecast for a 0.5% gain. In Europe, industrial production across the 18 country shared currency bloc rose by 0.2% in February from the prior month and by 1.7% from the same month of the prior year. COMPANY NEWS: Citigroup (C) gained $1.99, or 4.36%, to $47.67 after its adjusted first quarter earnings easily beat the consensus forecast. CEO Michael Corbat said the company delivered strong results despite a quarter "that was difficult," which included the bank surprisingly having its capital plan rejected by the Federal Reserve and the disclosure of fraud in its Mexican unit... Twitter (TWTR) shares held up better than they have in recent sessions after its co-founders, Jack Dorsey and Evan Williams, along with CEO Richard Costolo, disclosed that they have no plans to sell any of their shares as part of the May 5 lockup expiration... Edwards Lifesciences (EW) gained $8.03, or 11.0%, to $81.00 after being granted a preliminary injunction limiting the sale of Medtronic's (MDT) CoreValve system in the U.S. due to patent infringement. The ruling triggered upgrades of Edwards' shares from at least two analyst firms. Medtronic, which received at least one downgrade following the news, slipped $1.12, or 1.89%, to $58.08. MAJOR MOVERS: Among the notable gainers was Goodrich Petroleum (GDP), which surged $5.56, or 30.22%, to $23.96 after the company reported strong results for a well it drilled in Louisiana. Also higher was Akebia (AKBA), which rose $4.28, or 25.39%, to $21.14 after no fewer than four analyst firms initiated coverage on the shares with a Buy or equivalent rating. Among the noteworthy losers was NQ Mobile (NQ), which fell another $1.65, or 12.99%, to $11.05, adding to the 20% decline it suffered Friday after the company disclosed accounting errors along with its mixed earnings report. Short-seller Muddy Waters, which revealed a public short position on NQ in October, released a report today saying NQ's disappointing quarter was driven by heightened auditor scrutiny. Also lower Retrophin (RTRX), which dropped $2.35, or 15.3%, to $13.01 despite raising its fiscal 2014 revenue view after announcing that the FDA is unwilling to grant expedited access for children to the company's RE-024 treatment. INDEXES: The Dow was up 146.49, or 0.91%, to 16,173.24, the Nasdaq was up 22.96, or 0.57%, to 4,022.69, and the S&P 500 was up 14.92, or 0.82%, to 1,830.61.
News For C;TWTR;EW;MDT;GDP;AKBA;NQ;RTRX From The Last 14 Days
Check below for free stories on C;TWTR;EW;MDT;GDP;AKBA;NQ;RTRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
September 9, 2014
07:28 EDTTWTRThe Money Event, Inc to hold a conference
Subscribe for More Information
06:33 EDTCFed looks set to pressure large banks to shrink, NY Times says
Subscribe for More Information
06:32 EDTCCitigroup CFO says Q3 expenses up 'slightly' vs Q2, Reuters says
Subscribe for More Information
06:32 EDTCFed to require large US banks to have extra financial padding, WSJ reports
Subscribe for More Information
06:06 EDTRTRXRetrophin files $500M mixed securities shelf
06:01 EDTTWTRTwitter's Carolyn Penner to join Vine, Re/code reports
Subscribe for More Information
September 8, 2014
16:00 EDTTWTROptions Update; September 8, 2014
Subscribe for More Information
10:30 EDTTWTRTwitter moves higher on 'buy' button test, levels to watch
Subscribe for More Information
09:41 EDTCCitigroup CFO sees September trading to be better than August
Subscribe for More Information
09:30 EDTCCiti CFO says won't think about potential capital return until 'much later'
Subscribe for More Information
09:29 EDTCCitigroup CFO sees Q3 trading revenue 'in-line' with same quarter of last year
Subscribe for More Information
09:28 EDTCCitigroup sees consumer revenues up 'modestly' this quarter
Subscribe for More Information
09:18 EDTTWTRTwitter confirms test of 'Buy' button for select U.S. users
Subscribe for More Information
09:02 EDTCCitigroup says core Citicorp franchise growing loans, deposits
Subscribe for More Information
09:00 EDTCCitigroup names Peter Charrington as global head of citi Private Bank
Subscribe for More Information
07:24 EDTCBarclays to hold a conference
Global Financial Services Conference to be held in New York on September 8-10.
September 5, 2014
09:42 EDTTWTRTwitter management to meet with Deutsche Bank
Subscribe for More Information
09:06 EDTCCFTC concerned about banks shifting trading operations overseas, WSJ says
Subscribe for More Information
07:26 EDTCApple strikes transaction fee discount deals, Bank Innovation says
Apple (AAPL) has reached deals with American Express (AXP), JPMorgan (JPM), Citigroup (C), Capital One (COF), and Bank of America (BAC) to lower card transaction fees for its soon to be launched payments venture, said Bank Innovations, citing an earlier report from Tom Noyes and confirmation by its own sources. Apple has both convinced them to consider its transactions as “card present,” which carries a lower discount rate, and has also managed to bump down the actual “card present” rate by 15 to 25 basis points, according to people with knowledge of the matter, the report noted. Reference Link
06:11 EDTMDTMedtronic Linq device being underappreciated, says Citigroup
Citigroup believes the Street is underestimating the near-term potential of Medtronic's recently released Reveal Linq insertable cardiac monitor. Citi thinks the combination of the U.S. Corevalve rollout and Linq contribution will drive sales to the high end of the company's 3%-5% guidance. The firm raised its price target for shares to $74 from $73 and keeps a Buy rating on the stock.
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use